BioAtla, Inc. BCAB

Full chart Compare
Set alert

Price alert · BCAB

All alert types
2.00 USD +0.13 (+6.95%)

Nov 4, 2026, 1:45 PM EST

1.87 Day range 2.00
1.07 52-week range 71.50
YTD
-92.96%
1 year
-93.98%

Revenue & Expenses

Other Operating Income → Expenses: $42.97MExpenses → Gross Loss: $41.07MExpenses → Selling, General & Admin: $17.63MExpenses → Research & Development: $43.57MExpenses → Other Expenses: $302.00KNet Loss → Expenses: $59.61MRevenue → Cost of Revenue: $2.00MOther Operating Income$42.97MNet Loss$59.61MCost of Revenue$43.07MExpenses$102.58MGross Loss$41.07MSelling, General & Admin$17.63MResearch & Development$43.57MOther Expenses$302.00KRevenue$2.00M

Latest period ending Dec 31, 2025 · select a line to chart its full history

BCAB annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
2.00M11.00M00250.00K
2.00M11.00M00250.00K
-59.30M-73.94M-129.69M-108.14M-96.44M
-59.61M-69.78M-123.46M-106.48M-95.40M
-50.00-72.00-129.00-137.00-138.00
BCAB annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
7.12M49.05M111.47M215.51M244.98M
13.83M52.42M119.66M225.74M254.42M
50.02M38.16M48.99M45.40M43.60M
6.20M836.00K2.46M3.98M5.37M
-36.19M14.27M70.67M180.34M210.82M
BCAB annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-48.20M-71.94M-104.02M-90.42M-62.21M
6.28M9.51M77.00K61.21M69.51M
-41.93M-62.42M-104.04M-29.47M6.37M